{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:02:35Z","timestamp":1717826555190},"reference-count":17,"publisher":"Japanese Society of Internal Medicine","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,9,15]]},"DOI":"10.2169\/internalmedicine.2456-18","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T22:03:35Z","timestamp":1559858615000},"page":"2695-2698","source":"Crossref","is-referenced-by-count":5,"title":["Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S)"],"prefix":"10.2169","volume":"58","author":[{"given":"Taku","family":"Nakase","sequence":"first","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"},{"name":"Amyloidosis Medical Practice Center, Kumamoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiya","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Sasada","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Kumamoto University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruaki","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Misumi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotaro","family":"Takamatsu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seitaro","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaro","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Oita Japanese Red Cross Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konen","family":"Obayashi","sequence":"additional","affiliation":[{"name":"Department of Morphological and Physiological Sciences, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Kumamoto University Hospital, Japan"},{"name":"Department of Molecular Laboratory Medicine, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Ando","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuharu","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 7: 1-5, 2019."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ando Y, Nakamura M, Araki S. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 62: 1057-1062, 2005.","DOI":"10.1001\/archneur.62.7.1057"},{"key":"3","unstructured":"3. Sekijima Y, Ueda M, Koike H, Misawa S, Ishii T, Ando Y. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet J Rare Dis 13: 6, 2018."},{"key":"4","unstructured":"4. Masuda T, Ueda M, Kitajima M, et al. Teaching neuroImages: morphology of lumbosacral dorsal root ganglia and plexus in hereditary transthyretin amyloidosis. Neurology 91: e1834-e1835, 2018."},{"key":"5","unstructured":"5. Koike H, Misu K, Ikeda S, et al.; Study Group for Hereditary Neuropathy in Japan. Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. Arch Neurol 59: 1771-1776, 2002."},{"key":"6","unstructured":"6. Yamashita T, Ueda M, Misumi Y, et al. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. J Neurol 265: 134-140, 2018."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yamashita T, Ueda M, Saga N, et al. Hereditary amyloidosis with cardiomyopathy caused by the novel variant transthyretin A36D. Amyloid 23: 207-208, 2016.","DOI":"10.1080\/13506129.2016.1202228"},{"key":"8","unstructured":"8. Adams D, Gonzalez-Duarte A, O'Riordan WD, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med 379: 11-21, 2018."},{"key":"9","unstructured":"9. Benson MD, Waddington-Cruz M, Berk JL, et al. Inotersen treatment for patients with hereditary transthyretin amyloidosis. N Engl J Med 379: 22-31, 2018."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Coelho T, In\u00eas M, Concei\u00e7\u00e3o I, Soares M, de Carvalho M, Costa J. Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy. Neurology 91: e1999-e2009, 2018.","DOI":"10.1212\/WNL.0000000000006543"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Yamashita T, Ando Y, Okamoto S, et al. Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy. Neurology 78: 637-643, 2012.","DOI":"10.1212\/WNL.0b013e318248df18"},{"key":"12","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(94)90113-9","volume":"343","author":"Y Ando","year":"1994","unstructured":"12. Ando Y, Obayashi K, Tanaka Y, et al. Radiolabelled meta-iodobenzylguanidine in assessment of autonomic dysfunction. Lancet 343: 984-985, 1994.","journal-title":"The Lancet","ISSN":"http:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Maurer MS, Schwartz JH, Gundapaneni B, et al.; ATTR-ACT Study Investigators. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379: 1007-1016, 2018.","DOI":"10.1056\/NEJMoa1805689"},{"key":"14","unstructured":"14. Koike H, Tanaka F, Hashimoto R, et al. Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. J Neurol Neurosurg Psychiatry 83: 152-158, 2012."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sekijima Y, Yazaki M, Ueda M, Koike H, Yamada M, Ando Y. First nationwide survey on systemic wild-type ATTR amyloidosis in Japan. Amyloid 25: 8-10, 2018.","DOI":"10.1080\/13506129.2017.1409706"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yamashita T, Ando Y, Ueda M, et al. Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy. Neurology 70: 123-128, 2008.","DOI":"10.1212\/01.wnl.0000287089.28847.b5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Sekijima Y, Campos RI, Hammarstr\u00f6m P, et al. Pathological, biochemical, and biophysical characteristics of the transthyretin variant Y114H (p.Y134H) explain its very mild clinical phenotype. J Peripher Nerv Syst 20: 372-379, 2015.","DOI":"10.1111\/jns.12143"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/18\/58_2456-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T03:38:29Z","timestamp":1569037109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/18\/58_2456-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,15]]},"references-count":17,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2456-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,15]]}}}